American Journal Of Biomedical Science & Pharmaceutical Innovation
51
https://theusajournals.com/index.php/ajbspi
VOLUME
Vol.05 Issue04 2025
PAGE NO.
51-55
10.37547/ajbspi/Volume05Issue04-12
Analysis of The Sale of Adaptogenic Drugs in The
Republic of Uzbekistan
Djalilova Hanifa Mirkomil kizi
Tashkent Research Institute of Vaccines and Serums, Research Fellow, Uzbekistan
Ashurov Abdurahman Akbaraliyevich
Tashkent Research Institute of Vaccines and Serums, Director, KfN, Uzbekistan
Kambarov Khusan Jahangirovich
Tashkent Pharmaceutical Institute, PhD., Uzbekistan
Received:
28 February 2025;
Accepted:
29 March 2025;
Published:
30 April 2025
Abstract:
This article provides an in-depth analysis of the sales of adaptogenic drugs in the pharmaceutical market
of Uzbekistan for the period 2021-2024. Key trends, changes in the market structure, the dynamics of the range
of pharmaceutical forms, pricing policy, and further development prospects were studied. Special attention was
paid to import dependence, localization of production, and the introduction of new technologies. The presented
data are visualized in the form of diagrams and graphs.
Keywords:
Adaptogenic drugs, pharmaceutical market, import substitution, dosage forms, local production,
marketing strategy, innovation, state support.
Introduction:
Adaptogenic drugs contribute to
increasing the div's resistance to physical, mental,
and emotional stress. They are widely used in medicine
to correct conditions caused by stress, fatigue, and
decreased immunity. [1] In Uzbekistan, the adaptogen
market has long been dependent on imported supplies,
which has affected their availability and cost. However,
in recent years, there has been a trend towards
developing local production, which contributes to
reducing dependence on foreign manufacturers and
increasing the availability of medicines for the
population. [2] This work is aimed at studying the
dynamics of the adaptogenic drugs market in the
country for the period 2021-2024
Relevance
. The relevance of this topic lies in several key
aspects:
1. Growing demand for adaptogenic drugs - the
population is increasingly favoring natural and safe
methods of maintaining health, which increases
interest in adaptogens.
2. Import dependence and the need for local
production - reducing the share of imported drugs and
developing the national pharmaceutical sector will help
improve the availability and reduce the cost of
adaptogens for consumers. [3]
3. State support for pharmaceuticals - Uzbekistan is
experiencing
active
development
of
the
pharmaceutical industry, including import substitution
programs and investments in local production. Decree
of the President of the Republic of Uzbekistan Sh.M.
Mirziyoyev. PF-13 January 28, 2024:
To accelerate the development of the pharmaceutical
industry, significantly increase the volume of attracted
investments and exports, as well as ensure the
availability of high-quality, safe, and effective
medicines for the population. [4]
4. Export potential - the expansion of the Uzbek
pharmaceutical market to neighboring countries
(Kazakhstan, Tajikistan, Turkmenistan) opens up new
business opportunities.
American Journal of Applied Science and Technology
52
https://theusajournals.com/index.php/ajast
American Journal of Applied Science and Technology (ISSN: 2771-2745)
5. The change in consumer preferences - the growing
interest in tea mixtures and dry extracts - confirms the
trend towards natural dosage forms.
METHODOLOGY
The study is based on the analysis of the State Register
of Medicines, open sources, as well as marketing
reports of large pharmaceutical companies. Content
analysis, comparative analysis, and structural and
dynamic analysis of market indicators were used.
Additionally, interviews were conducted with
representatives of pharmaceutical companies, industry
experts, and doctors who use adaptogenic drugs in
their practice. Based on the obtained data, market
development forecasts were made.
According to BusinesStat, the production of medicines
in Uzbekistan increased by 3% in 2023 and reached 565
million packages. This trend has also affected the
adaptogen segment, which is experiencing a steady
increase in demand due to the growing interest in
natural preparations.
Main market trends (2021-2024)
Import dependency and local production
• In 2021
-2023, imported drugs accounted for 90-91%
of the market.
• In 2024, dependency decreased to 76%, which
indicates an increase in the share of local production.
• Main supplier countries:
2021-2023: Pakistan (59.1%), India (8.8%), China
(14.2%), Germany (7%), Bulgaria (7%), USA (4.8%).
o 2024: India (19%), China (14.2%), Pakistan (14.2%),
Russia (14.2%), Turkey (4.8%), USA (4.8%).
The market also features foreign brands, such as:
- Imperial Adaptogen (Paradise Herbs) - a complex of
concentrated adaptogens.
- Solgar Rhodiola Root Extract is a preparation based on
pink radish.
Imported drugs occupy a significant portion of the
market, but their cost is higher compared to domestic
analogues.
0
10
20
30
40
50
Syrups
tablets
capsules
dragee
granules
tea mixtures
dry extrakt
MARKET SHARE %
dynamics of the range medicinal
forms of adaptogens
2021-2023
2024
0
10
20
30
40
50
60
70
80
90
100
local
imported
RELATIVE VALUE (UNIT)
comparison of price adaptogenic
drugs(2021 and 2024)
2021
2024
American Journal of Applied Science and Technology
53
https://theusajournals.com/index.php/ajast
American Journal of Applied Science and Technology (ISSN: 2771-2745)
The share of local producers increased from 4% in 2021
to 9.8% in 2024.
• The development of local production is due to
government support, the introduction of subsidies for
pharmaceutical companies, and investments in the
development of pharmaceutical production.
Price policy
• In 2021, imported drugs were 4
-7 times more
expensive than local ones.
• In 2024, the price gap has decreased, but imported
medicines remain more expensive than their local
counterparts.
• The average cost of imported adaptogens is
70,000
UZS, while local analogues cost 30,000 UZS.
• The highest price increase was recorded in the plant
adaptogen segment, which is associated with an
increase in raw material costs and logistics costs.
Dynamics of the range of medicinal forms
Dosage form 2021-2023 (market share) 2024 (market
share)
Syrups 45% 23.8%
Tablets 21.4% 21.4%
Capsules 16.6% 16.6%
Dragee 14.2% 14.2%
Granules 9.5% 9.5%
Tea mixtures - 7.1%
Dry extracts 7.1% 7.1%
• The proportion of syrups decreased by 21.2%, which
may be related to increased interest in more
convenient forms of administration, such as tablets and
capsules.
• The popularity of tea and dr
y extracts is growing,
which is due to increased interest in natural medicine.
0
5
10
15
20
25
30
35
40
45
Russia
China
USA
Other
M
A
R
KE
T S
H
A
R
E
(%
)
COUNTRY OF ORIGIN
structure of import adaptogens to Uzbeistan
0
50000
100000
150000
200000
250000
300000
Tribestan
Prolarge
Ginsomin Eva
Velson
Viraton
Minorishan
Vivabon
Ginseng tincture
AVERAGE PRICT (UZS)
Top-selling adaptogenic drugs in
Uzbekistan (2021-2024)
American Journal of Applied Science and Technology
54
https://theusajournals.com/index.php/ajast
American Journal of Applied Science and Technology (ISSN: 2771-2745)
Pharmaceutical sector development prospects
1. Expansion of local production
o Development of adaptogens based on local plant raw
materials.
o Increasing investments in the pharmaceutical
industry.
o Improvement of production technological processes.
2. Stimulation of import substitution
o Support for domestic producers at the state level.
o Reducing the tax burden for local pharmaceutical
companies.
3. Development of export potential
o Access to the markets of neighboring countries such
as Kazakhstan, Tajikistan, and Turkmenistan.
o Promotion of Uzbek adaptogens at international
pharmaceutical exhibitions.
4. Improvement of marketing strategies
Introduction of loyalty programs for consumers.
o Conducting information campaigns about the
benefits of adaptogens.
Forecast
It is expected that by 2026, the adaptogen market in
Uzbekistan will grow by another 10-15%, which will
contribute to:
- Increased interest in natural remedies.
- Expanding the range of local producers.
- State initiatives for the development of the
pharmaceutical sector.
Graph 4: Growth forecast of the adaptogen market in Uzbekistan (2024-2026)
The market for adaptogenic drugs in Uzbekistan is
showing positive dynamics due to the demand for
natural products. Local producers are gradually
strengthening their positions, but imports remain a
significant part of the segment. In the future, we can
expect to increase production and expand the range,
which will lead to a decrease in dependence on foreign
supplies and an increase in the availability of
0
20
40
60
80
100
2021
2022
2023
2024
YEAR
Dynamics of import and production of adaptogens
in Uzbekistan
import(%)
local production(%)
580
590
600
610
620
630
2024
2025
2026
PRODUC
TION
V
O
LUM
E
(M
IL
LIO
N
PA
SKA
GE
S)
YEAR
Adaptogens Market Growth Forecast (2024 -2026)
American Journal of Applied Science and Technology
55
https://theusajournals.com/index.php/ajast
American Journal of Applied Science and Technology (ISSN: 2771-2745)
adaptogens for the population.
CONCLUSION
During the period 2021-2024, the adaptogenic drug
market in Uzbekistan demonstrated a stable trend
towards increased local production and reduced
import dependence. However, the share of imported
drugs remains high (76%), and the price difference
between local and foreign adaptogens persists. For
further market development, it is necessary to actively
stimulate local production, provide state support, and
introduce innovations to enhance the competitiveness
of Uzbek manufacturers.
REFERENCES
Kurkin V.A., Petrukhina I.K., Akushskaya A.S. Study of
the nomenclature of adaptogenic drugs presented on
the pharmaceutical market of the Russian Federation
fundamental research No. 8, 2014, pp. 898-902
H. K. Bekchanov, kh. J. Kambarov, l. M. Jalilov, kh. M.
Djalilova, l. S’h. Yakubova, j. S’h. S’hoymurodov.
Development of the composite a\d technology of
capsules of the medicinal preparation containing the
dry yextract “s’harq tab1bi” journal of human
university, (natural sciences) vol. 48. No. 8. August
2021, 176-185.
Evolution of the adaptogenic concept from traditional
use to medical systems: pharmacology of stress- and
ging-related diseases. Review a r t i c l e
wileyonlinelibrary.com/journal/med med res rev.
2021; 41:630
–
703.
State Register of Medicines and Medical Devices
Registered in the Republic of Uzbekistan - No. 25 of
2021.
